Navigation Links
SkinMedica(R) Launches NeoBenz(R) Micro Wash for Acne
Date:1/14/2009

Only Benzoyl Peroxide Wash to Utilize MICROSPONGE(R) Delivery System

CARLSBAD, Calif., Jan. 14 /PRNewswire/ -- SkinMedica, Inc. today announced the launch of NeoBenz Micro Wash, the only prescription benzoyl peroxide wash product formulated with the MICROSPONGE(R) delivery system, for the treatment of mild to moderate acne vulgaris. NeoBenz Micro Wash contains 7% benzoyl peroxide.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090114/LA58962)

NeoBenz Micro Wash follows on the success of NeoBenz Micro Cream and NeoBenz Micro SD which launched in January of 2006 and January of 2007, respectively. Within one year of launch, NeoBenz Micro Cream became the most-prescribed benzoyl peroxide cream or gel by dermatologists.

"NeoBenz Micro Wash is a cosmetically elegant, easy to lather formulation and the only benzoyl peroxide wash medication to utilize the benefits of the MICROSPONGE(R) delivery system. The benzoyl peroxide entrapped microspheres have been shown to remain on the skin post-rinse. This slow release of benzoyl peroxide provides a lower incidence of irritation which may result in improved compliance and better therapeutic results," said Rex Bright, president at SkinMedica.

The clinical benefits of NeoBenz Micro Wash were evaluated in a randomized, investigator-blinded trial comparing the tolerability of NeoBenz Micro Wash with a non-medicated gentle cleansing wash. Forty-six (46) mild to moderate acne patients were assigned to receive once daily treatment with one of the washes for 21 days. Results showed that both groups exhibited excellent local cutaneous tolerability and mean scores measurable at baseline were minimal and improved during the course of the study. There were no statistical differences between the
'/>"/>

SOURCE SkinMedica, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. SkinMedica(R) Launches New Informational Web Site
2. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
3. UPMC Health Plan Launches New Personal Health Record
4. HealthInsuranceFinders.com Launches Video Contest for Young Directors
5. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
6. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
7. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
8. Mannatech Launches Phase One of New Sales and Training Tools
9. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
10. Actavis Launches Carvedilol Tablets in the U.S.
11. MedQuist Re-launches New, Improved Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Helping to Clear the Air for Consumers - New Certification Standard for HEPA Filters Will Help Millions of People Make More Educated Choices 2Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 2Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 3Health News:SAFC Supply Solutions Introduces Certified Organics to Flavors & Fragrances Product Line 4Health News:Official Launch of ABLE TO CHOOSE Public Awareness Campaign 2Health News:Breast Cancer Action Victorious in Yoplait 'Pinkwashing' Campaign 2Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 2Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 3Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 4Health News:During National Wise Health Consumer Month: Consumers Seek Cost-Effective Health Care 5Health News:Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls 2Health News:Autism Consortium members publish in PNAS: Mechanism, treatment for Rett syndrome -- top cause autism girls 3
Breaking Medicine Technology:FDA Launches Orphan Drug Workshop at KGI 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Adva 52876 1MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Adva 52876 2MoviMED Announces Participation in NIWeek 2009 Conference to Examine Trends and Technologies for Boosting Productivity and Increasing Competitive Adva 52876 3Huntsville Alabama Plastic Surgeon David L Durst MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market 52871 1Huntsville Alabama Plastic Surgeon David L Durst MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market 52871 2Huntsville Alabama Plastic Surgeon David L Durst MD Comments on Silicone Breast Implants after Nearly 3 Years on the Open Market 52871 3FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 1FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 2FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 3FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 4FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 5FDA Issues Complete Response Letter for INTUNIV 28TM 29 28guanfacine 29 Extended Release for the Treatment of ADHD in Children and Adolescents 4786 6